WallStreetZenWallStreetZen

NASDAQ: RAIN
Rain Therapeutics Inc Stock

Open Broker Account
$4.88-0.75 (-13.32%)
Updated Sep 30, 2022
RAIN Price
$4.88
Fair Value Price
$6.52
Market Cap
$129.64M
52 Week Low
$2.15
52 Week High
$17.31
P/E
-1.8x
P/B
1.32x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$71.42M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.13
Operating Cash Flow
-$56M
Beta
1.27
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how RAIN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

RAIN ($4.88) is undervalued by 25.11% relative to our estimate of its Fair Value price of $6.52 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
RAIN ($4.88) is significantly undervalued by 25.11% relative to our estimate of its Fair Value price of $6.52 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
RAIN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more RAIN due diligence checks available for Premium users.

Be the first to know about important RAIN news, forecast changes, insider trades & much more!

RAIN News

Valuation

RAIN fair value

Fair Value of RAIN stock based on Discounted Cash Flow (DCF)
Price
$4.88
Fair Value
$6.52
Undervalued by
25.11%
RAIN ($4.88) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
RAIN ($4.88) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
RAIN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

RAIN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.8x
Industry
14.28x
Market
27.64x

RAIN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.32x
Industry
4.39x
RAIN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

RAIN's financial health

Profit margin

Revenue
$0.0
Net Income
-$17.6M
Profit Margin
0%
RAIN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$110.7M
Liabilities
$12.4M
Debt to equity
0.13
RAIN's short-term assets ($109.61M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RAIN's short-term assets ($109.61M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RAIN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$17.4M
Investing
$39.3M
Financing
$12.0k
RAIN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

RAIN vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
RAIN$129.64M-13.32%-1.80x1.32x
OVID$129.57M-2.65%-1.88x0.85x
IKNA$128.71M-4.57%-2.96x0.74x
FUSN$130.61M+1.69%-1.72x0.66x
ORIC$126.65M-1.23%-1.49x0.53x

Rain Therapeutics Stock FAQ

What is Rain Therapeutics's quote symbol?

NASDAQ: RAIN) Rain Therapeutics trades on the NASDAQ under the ticker symbol RAIN. Rain Therapeutics stock quotes can also be displayed as NASDAQ: RAIN.

If you're new to stock investing, here's how to buy Rain Therapeutics stock.

What is the 52 week high and low for Rain Therapeutics (NASDAQ: RAIN)?

(NASDAQ: RAIN) Rain Therapeutics's 52-week high was $17.31, and its 52-week low was $2.15. It is currently -71.81% from its 52-week high and 126.98% from its 52-week low.

How much is Rain Therapeutics stock worth today?

(NASDAQ: RAIN) Rain Therapeutics currently has 26,564,823 outstanding shares. With Rain Therapeutics stock trading at $4.88 per share, the total value of Rain Therapeutics stock (market capitalization) is $129.64M.

Rain Therapeutics stock was originally listed at a price of $15.80 in Apr 23, 2021. If you had invested in Rain Therapeutics stock at $15.80, your return over the last 1 years would have been -69.11%, for an annualized return of -69.11% (not including any dividends or dividend reinvestments).

How much is Rain Therapeutics's stock price per share?

(NASDAQ: RAIN) Rain Therapeutics stock price per share is $4.88 today (as of Sep 30, 2022).

What is Rain Therapeutics's Market Cap?

(NASDAQ: RAIN) Rain Therapeutics's market cap is $129.64M, as of Oct 2, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Rain Therapeutics's market cap is calculated by multiplying RAIN's current stock price of $4.88 by RAIN's total outstanding shares of 26,564,823.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.